Health
Covaxin: India’s first Coronavirus vaccine candidate approved for human trials. Here’s all you need to know – Times of India
India’s drug control authority, the Central Drugs Standard Control Organisation (CDSCO) has allowed BBIL to hold Phase I and II of human clinical trials, which are scheduled to start across India in July.
Covaxin is the first indigenous vaccine candidate to fight against the novel coronavirus, created and developed by BBIL. It is the first vaccine candidate to be approved for human trials.
According …
Continue Reading
-
Noosa News19 hours agoElderly pair killed in rural highway intersection crash with caravan
-
General12 hours agoThe wrong way to respond to antisemitism • Inside Story
-
Business20 hours ago3 of the best ASX shares to buy with $5,000
-
Business16 hours agoUp 29% since April, why is this ASX 200 coal stock tumbling today?